FDA Inspection 1067153 — Texas Health Presbyterian Hospital Of Dallas Blood Bank
The FDA completed an inspection of Texas Health Presbyterian Hospital Of Dallas Blood Bank on Sep 12, 2018 in Dallas, TX. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Sep 12, 2018
- Fiscal Year
- 2018
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Dallas, TX (United States)